This market resolves to Yes if Hims & Hers formally announces the integration of Novo Nordisk's obesity drugs into their telehealth platform with at least one official product or service launch related to the drugs by December 31, 2026. Verification will be done through official press releases from either Hims & Hers or Novo Nordisk.